18:22 , Apr 13, 2018 |  BC Extra  |  Preclinical News

NCI identifies new lymphoma subtypes

A New England Journal of Medicine paper out of NIH's National Cancer Institute revealed new subtypes of diffuse large B cell lymphomas (DLBCL) that could lead to more targeted therapeutic strategies. The report adds to...
07:00 , Jul 22, 2013 |  BC Week In Review  |  Company News

General Electric sales and marketing update

General Electric's Clarient Diagnostic Services Inc. company launched the Hodgkin Lymphoma Profile by MultiOmyx test to aid in the diagnosis of CD30-positive lymphoma with difficult morphology or otherwise insufficient tissue. The test uses Clarient's MultiOmyx...
08:00 , Mar 2, 2009 |  BC Week In Review  |  Company News

Celerus sales and marketing update

Celerus launched 12 antibodies to be used on its Celerus Wave System for immunohistochemistry analysis. The antibodies target CD7, CD8 , neutral endopeptidase (MME) (NEP) (CD10) , CD30 , CD34, CD79a, c-kit proto-oncogene protein (KIT,...